COVID-19 and immune checkpoint inhibitors: initial considerations. Read more about COVID-19 and immune checkpoint inhibitors: initial considerations.
Combination immunotherapy induces distinct T-cell repertoire responses when administered to patients with different malignancies. Read more about Combination immunotherapy induces distinct T-cell repertoire responses when administered to patients with different malignancies.
Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge 2018" (28-29 November, 2018, Naples, Italy). Read more about Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge 2018" (28-29 November, 2018, Naples, Italy).
Correction to: Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institution. Read more about Correction to: Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institution.
Immunotherapy in hepatocellular carcinoma: the complex interface between inflammation, fibrosis, and the immune response. Read more about Immunotherapy in hepatocellular carcinoma: the complex interface between inflammation, fibrosis, and the immune response.
Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institution. Read more about Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institution.
A case of checkpoint inhibitor-induced celiac disease. Read more about A case of checkpoint inhibitor-induced celiac disease.
Correction to: Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop. Read more about Correction to: Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop.
Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study. Read more about Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study.
Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop. Read more about Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop.
